Icecure Medical LTD

Shad Good, VP, Sales for North America of IceCure Medical Ltd., received 131,483 shares of common stock on August 14, 2026.

Tlalit Bussi Tel-Tzure, VP, BD & Global Marketing of IceCure Medical Ltd., received 101,483 shares of common stock on August 14, 2026.

Shay Levav, Chief Operating Officer of IceCure Medical Ltd., received 141,483 shares of common stock on August 14, 2026.

Merav Nir Dotan, VP, Human Resources of IceCure Medical Ltd., received 73,890 shares of common stock on August 14, 2026.

Meir Peleg, Chief Financial Officer of IceCure Medical Ltd., received 181,483 shares of common stock on August 14, 2026.

Vincent Chun Hung Chan, a Director of IceCure Medical Ltd., reported multiple transactions in common stock on August 12, 2026.

A significant shareholder's director, Mr. Li Haixiang, has resigned from the board of IceCure Medical Ltd., while the reporting persons maintain a 45.8% beneficial ownership stake.

Li Haixiang and Epoch Partner Investments Limited have disclosed a significant beneficial ownership of 45.7% in IceCure Medical Ltd., holding 25,846,597 ordinary shares for investment purposes.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 300,332 ordinary shares, representing 9.99% of IceCure Medical Ltd., as of June 30, 2026.